Imunon, Inc. (IMNN) Dividend History

ImmunoGen, Inc. (IMNN) is a biotechnology company focused on the development of targeted antibody-drug conjugates (ADCs) for the treatment of cancer. The company leverages its proprietary ADC technology to create therapies designed to deliver potent cancer-killing agents directly to tumor cells, aiming to improve efficacy and reduce side effects associated with traditional chemotherapy.

997 Lenox Drive, Lawrenceville, NJ, 08648
Phone: (609) 896-9100
Website: https://www.imunon.com

Dividend History

Imunon, Inc. currently does not pay dividends

Company News

  • IMUNON, a clinical-stage biotechnology company, announced a $3.25 million private placement and the potential for an additional $6.5 million from the exercise of short-term warrants. The company plans to use the proceeds for working capital and general corporate purposes.

    GlobeNewswire Inc.
  • Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. Bumble reported quarterly losses of 19 cents per share which missed the analyst consensus estimate of 12 cents per share. The company reported quarterly sales of $273.64 million which missed the analyst consensus estimate of $275.29 million. Bumble shares dipped 11.6% to $11.65 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Vivani Medical, Inc. (NASDAQ: VANI) shares jumped 289% to $3.93 after the company announced preclinical data on weight loss effects for NPM-115 and disclosed that semaglutide is the active pharmaceutical ingredient in NPM-139. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) climbed 190% to $2.4598. Adial Pharmaceuticals secured new US patent covering lead product for alcohol use disorder. vTv Therapeutics Inc. (NASDAQ: VTVT) gained 112% to $17.65 after the company announced a $51 million private placement from healthcare-focused institutional investors and the JDRF T1D Fund. Bit Brother Limited (NASDAQ: BETS) shares rose 63.7% to $4.0750. Beyond Meat, Inc. (NASDAQ: BYND) climbed 45% to $10.90 as the company reported stronger-than-expected sales for its fourth quarter. Incannex Healthcare Inc. (NASDAQ: IXHL) gained 43.6% to $6.06 after the company announced its Psi-GAD1 trial met its primary endpoint. Bandwidth Inc. (NASDAQ: BAND) surged 43.3% to $17.41 after the company reported better-than-expected fourth quarter financial results and issued FY24 revenue guidance above estimates. Imunon, Inc. (NASDAQ: IMNN) climbed 38% to $0.98. Applied Therapeutics, Inc. (NASDAQ: APLT) surged 36% to $7.59 after the company announced FDA acceptance and priority review of the NDA for govorestat for the treatment of Classic Galactosemia. The company also announced a $100 million private placement. Movella Holdings Inc. (NASDAQ: MVLA) gained 33.5% to $0.33. LifeStance Health Group, Inc. (NASDAQ: LFST) gained 31.5% to $8.81 following strong quarterly sales. AirNet Technology Inc. (NASDAQ: ANTE) rose 31.3% to $1.05. AirNet announced changes in senior management team. Polestar Automotive Holding UK PLC (NASDAQ: PSNY) rose 29.9% to $1.9350. Polestar secured $1 billion external funding. Editas Medicine, Inc. (NASDAQ: EDIT) gained 27.7% to $11.31 after the company reported better-than-expected fourth-quarter financial results. TG Therapeutics, ...

    Benzinga
Page data last updated 07/23/2025 01:56:20 UTC